Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a daily probiotic soothe baby eczema?

NCT ID NCT05286047

Completed Symptom relief Sponsor: Glac Biotech Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a daily probiotic called Bifidobacterium longum CCFM1029 can reduce eczema symptoms in infants aged 3 months to 3 years. One hundred children with atopic dermatitis were split into two groups: one received the probiotic and the other a placebo for 3 months. Researchers tracked changes in eczema severity and gut bacteria to see if the probiotic helps calm inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bifidobacterium longum CCFM1029 (a probiotic dietary supplement)
What this could lead to
If it works, this could point toward a simple, safe probiotic option to help manage eczema in infants.
What could go wrong
This is a small, early-stage trial with only 100 participants. The effect may be modest or not better than placebo, and results may not apply to all infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Locations

  • Glac Biotech Co., Ltd.

    Tainan, 74442, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.